VectivBio AG is a company that provides Teduglutide, Rare disease, Biotechnology and more. VectivBio AG is headquartered in Switzerland Basel-Stadt. VectivBio AG was founded in 2019. VectivBio AG has a total of 26 patents
VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing...
What is VectivBio AG's official website?
VectivBio AG's official website is http://www.vectivbio.com.